Skip to main content

Advertisement

Table 1 Study subject serology results and indicators

From: Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user

Subjects HCV PCR Copies per ml (Date of test) HepBsAb HepBsAg HepBcAb HIV Viral Load Copies per ml ALT U/L Liver Biopsy
1 10,800,000 (11/99) Neg Neg Pos 633 (12/03) 32 (12/03) Activity: Mild Stage 2 of 4 (08/00)
  34,500,000 IU (12/03)     270,000 (01/03)   
2 8,360,000 (09/99) Neg Neg Pos 180,000 (10/03) 16 (02/04) Not done due to bleeding diathesis
      96,000 (02/04) 16 (10/03)  
3 1,320,000 (10/03) Pos Neg Pos 16,900 (02/04) 110 (10/03) Grade 2/3 of 4 Stage 2/3 of 4 (11/03)
       182 (02/04)  
4 234,000 (12/02) Neg Neg Neg 72,031 (12/02) 37 (12/03) Grade 1 of 4 Stage 1 of 4 (11/03)
      <50 (12/03)   
5 <600 Neg Neg Pos 212,000 (10/03) 41 (10/03) Not done
       104 (04/04)  
  1. HCV = hepatitis C virus; HepB = hepatitis B; s = surface; c = core; Ab = antibody; Ag = antigen; HIV = human immunodeficiency virus; ALT = alanine aminotransferase enzyme